Tower Research Capital (TRC)’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.3K | Buy |
8,005
+5,231
| +189% | +$26.4K | ﹤0.01% | 3154 |
|
|
2025
Q1 | $18K | Sell |
2,774
-58,617
| -95% | -$380K | ﹤0.01% | 3075 |
|
|
2024
Q4 | $451K | Buy |
61,391
+46,378
| +309% | +$340K | 0.01% | 1145 |
|
|
2024
Q3 | $112K | Sell |
15,013
-5,049
| -25% | -$37.8K | ﹤0.01% | 2140 |
|
|
2024
Q2 | $179K | Buy |
20,062
+19,081
| +1,945% | +$170K | ﹤0.01% | 2162 |
|
|
2024
Q1 | $9.94K | Sell |
981
-14,568
| -94% | -$148K | ﹤0.01% | 3774 |
|
|
2023
Q4 | $156K | Buy |
15,549
+11,278
| +264% | +$113K | ﹤0.01% | 2286 |
|
|
2023
Q3 | $40K | Sell |
4,271
-1,503
| -26% | -$14.1K | ﹤0.01% | 2737 |
|
|
2023
Q2 | $142K | Buy |
5,774
+2,073
| +56% | +$50.9K | ﹤0.01% | 1783 |
|
|
2023
Q1 | $86K | Sell |
3,701
-2,892
| -44% | -$67.2K | ﹤0.01% | 2009 |
|
|
2022
Q4 | $167K | Sell |
6,593
-104
| -2% | -$2.63K | 0.01% | 1429 |
|
|
2022
Q3 | $129K | Sell |
6,697
-19,975
| -75% | -$385K | ﹤0.01% | 2338 |
|
|
2022
Q2 | $680K | Buy |
26,672
+9,048
| +51% | +$231K | 0.02% | 942 |
|
|
2022
Q1 | $453K | Buy |
17,624
+1,763
| +11% | +$45.3K | ﹤0.01% | 1201 |
|
|
2021
Q4 | $664K | Buy |
15,861
+13,507
| +574% | +$565K | 0.01% | 924 |
|
|
2021
Q3 | $103K | Sell |
2,354
-1,931
| -45% | -$84.5K | ﹤0.01% | 2377 |
|
|
2021
Q2 | $202K | Buy |
4,285
+1,946
| +83% | +$91.7K | 0.01% | 1917 |
|
|
2021
Q1 | $120K | Buy |
2,339
+961
| +70% | +$49.3K | ﹤0.01% | 2453 |
|
|
2020
Q4 | $37K | Sell |
1,378
-43,664
| -97% | -$1.17M | ﹤0.01% | 3401 |
|
|
2020
Q3 | $1.55M | Buy |
45,042
+41,351
| +1,120% | +$1.42M | 0.02% | 584 |
|
|
2020
Q2 | $151K | Buy |
+3,691
| New | +$151K | 0.01% | 2064 |
|
|
2020
Q1 | – | Sell |
-1,908
| Closed | -$24K | – | 3952 |
|
|
2019
Q4 | $24K | Buy |
+1,908
| New | +$24K | ﹤0.01% | 1816 |
|